Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neurotrope Announces First Patient Dosed in Bryostatin Trial for Alzheimer's Disease

americanpharmaceuticalreviewOctober 12, 2020

Tag: Neurotrope , Alzheimer's Disease , Bryostatin , Namenda

PharmaSources Customer Service